Peter Švec

1.3k total citations
27 papers, 374 citations indexed

About

Peter Švec is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Peter Švec has authored 27 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Oncology. Recurrent topics in Peter Švec's work include Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Peter Švec is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Childhood Cancer Survivors' Quality of Life (4 papers) and Hematopoietic Stem Cell Transplantation (4 papers). Peter Švec collaborates with scholars based in Slovakia, Czechia and Hungary. Peter Švec's co-authors include Barna Vásárhelyi, András Treszl, Tivadar Tulassay, János Rigó, G Mészáros, Gergely Toldi, Ján Sedlák, Alexandra Kolenová, Esko Kankuri and Bea Pászthy and has published in prestigious journals such as Blood, Scientific Reports and Journal of Autoimmunity.

In The Last Decade

Peter Švec

25 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Švec Slovakia 10 164 106 86 74 66 27 374
Alaa Amash Israel 14 172 1.0× 158 1.5× 47 0.5× 105 1.4× 180 2.7× 24 519
A. Inkeri Lokki Finland 15 295 1.8× 86 0.8× 52 0.6× 49 0.7× 340 5.2× 37 571
NANCY C. SMITH United States 5 162 1.0× 52 0.5× 99 1.2× 57 0.8× 173 2.6× 10 414
Jusciéle Brogin Moreli Brazil 11 104 0.6× 91 0.9× 75 0.9× 18 0.2× 203 3.1× 21 390
Shadi Eghbal‐Fard Iran 13 363 2.2× 158 1.5× 103 1.2× 30 0.4× 193 2.9× 16 574
Stephanie T. Page United States 12 151 0.9× 26 0.2× 108 1.3× 17 0.2× 31 0.5× 22 573
Janet E. Brennand United Kingdom 8 117 0.7× 164 1.5× 68 0.8× 31 0.4× 169 2.6× 13 423
Donald Adler United States 6 107 0.7× 109 1.0× 33 0.4× 13 0.2× 57 0.9× 8 296
Guido Marelli Italy 10 65 0.4× 183 1.7× 29 0.3× 32 0.4× 112 1.7× 13 427
J HUMPHREYS United Kingdom 7 163 1.0× 53 0.5× 62 0.7× 19 0.3× 71 1.1× 8 368

Countries citing papers authored by Peter Švec

Since Specialization
Citations

This map shows the geographic impact of Peter Švec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Švec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Švec more than expected).

Fields of papers citing papers by Peter Švec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Švec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Švec. The network helps show where Peter Švec may publish in the future.

Co-authorship network of co-authors of Peter Švec

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Švec. A scholar is included among the top collaborators of Peter Švec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Švec. Peter Švec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nováková, Michaela, Oscar Maglia, Angela Schumich, et al.. (2025). Flow-cytometric MRD detection in pediatric T-ALL: a multicenter AIEOP-BFM consensus-based guided standardized approach. Clinical Chemistry and Laboratory Medicine (CCLM). 63(7). 1419–1426. 1 indexed citations
2.
3.
4.
5.
Švec, Peter, et al.. (2023). The Importance of New EBMT Criteria on the Diagnosis of Veno-Occlusive Liver Disease in Children. Journal of Clinical Medicine. 12(3). 826–826. 4 indexed citations
6.
7.
Vettenranta, Kim, et al.. (2022). What Is the Role of HSCT in Philadelphia-Chromosome–Positive and Philadelphia-Chromosome–Like ALL in the Tyrosine Kinase Inhibitor Era?. Frontiers in Pediatrics. 9. 807002–807002. 1 indexed citations
8.
Nováková, Michaela, Markéta Žaliová, Karel Fišer, et al.. (2020). <i>DUX4r</i>, <i>ZNF384r</i> and <i>PAX5</i>-P80R mutated B-cell precursor acute lymphoblastic leukemia frequently undergo monocytic switch. Haematologica. 106(8). 2066–2075. 32 indexed citations
9.
Dalle, Jean‐Hugues, Adriana Balduzzi, Peter Bader, et al.. (2020). The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG. Bone Marrow Transplantation. 56(1). 257–266. 9 indexed citations
10.
Czyźewski, K, Petr Sedláček, Jaroslav Štěrba, et al.. (2020). Progress and trends in pediatric hematopoietic cell transplantation in Central-East European countries. Acta Haematologica Polonica. 51(3). 142–150. 8 indexed citations
11.
Boďová, Ivana, et al.. (2019). Diagnosis and treatment of juvenile myelomonocytic leukemia in Slovak Republic: novel approache. Neoplasma. 66(5). 818–824. 4 indexed citations
12.
13.
Морзе, Наталія, et al.. (2017). IT Tools in a University e-Learning Environment: Students’ Opinion Survey. CeON Repository (Centre for Evaluation in Education and Science). 1 indexed citations
14.
Švec, Peter, et al.. (2017). First case of invasive Magnusiomyces capitatus infection in Slovakia. Medical Mycology Case Reports. 16. 12–15. 11 indexed citations
15.
Švec, Peter & M Kuželová. (2012). 35 years of education in clinical pharmacology at the Faculty of Pharmacy in Comenius University. 59(Supplement-VI). 67–75.
16.
Vivante, Asaf, Danny Lotan, Naomi Pode‐Shakked, et al.. (2011). Familial Autosomal Recessive Renal Tubular Acidosis: Importance of Early Diagnosis. Nephron Physiology. 119(3). p31–p39. 8 indexed citations
17.
Švec, Peter, et al.. (2010). Resistance of Human Regulatory Foxp3+ T Cells to Normobaric Hyperoxia Exposure Under Resting and Stimulating Conditions. Scandinavian Journal of Immunology. 73(3). 215–221. 1 indexed citations
18.
Treszl, András, Peter Švec, Jane Marttila, et al.. (2008). Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant. Journal of Autoimmunity. 31(1). 13–21. 63 indexed citations
19.
Toldi, Gergely, Peter Švec, Barna Vásárhelyi, et al.. (2008). Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstetricia Et Gynecologica Scandinavica. 87(11). 1229–1233. 88 indexed citations
20.
Švec, Peter, Barna Vásárhelyi, Bea Pászthy, et al.. (2007). Do regulatory T Cells Contribute to Th1 Skewness in Obesity?. Experimental and Clinical Endocrinology & Diabetes. 115(7). 439–443. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alaa Amash Breakdown of academic impact, for papers by A. Inkeri Lokki Breakdown of academic impact, for papers by NANCY C. SMITH Breakdown of academic impact, for papers by Jusciéle Brogin Moreli Breakdown of academic impact, for papers by Shadi Eghbal‐Fard Breakdown of academic impact, for papers by Stephanie T. Page Breakdown of academic impact, for papers by Janet E. Brennand Breakdown of academic impact, for papers by Donald Adler Breakdown of academic impact, for papers by Guido Marelli Breakdown of academic impact, for papers by J HUMPHREYS
Rankless by CCL
2026